Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2 V617F mutation

Blood (2013) 121 (2): 360–368.

https://doi.org/10.1182/blood-2012-01-404889

Published: 2013

Includes: Supplemental data

Journal Articles

JAK2 exon 14 Skipping in Patients with Primary Myelofibrosis (PMF),

Paolo Catarsi, PhD, Vittorio Rosti, MD, Vittorio Abbonante, BS, Alessandra Balduini, MD, Gaetano Bergamaschi, MD, Elisa Bonetti, Biol Sci, Valentina Poletto, Biol Sci, Laura Villani, Biol Sci, Giovanni Barosi, MD

Blood (2011) 118 (21): 3844.

https://doi.org/10.1182/blood.V118.21.3844.3844

Published: 2011

Journal Articles

The Effects of Mitochondrial Ferritin Expression in Normal and Sideroblastic Erythropoiesis.

Matteo G Della Porta, Vittorio Rosti, Anna Gallì, Erica Travaglino, Paolo Santambrogio, Carmela Marseglia, Valentina Matti, Luca Malcovati, Gaetano Bergamaschi, Sonia Levi, Rosangela Invernizzi, Mario Cazzola

Blood (2009) 114 (22): 736.

https://doi.org/10.1182/blood.V114.22.736.736

Published: 2009

Journal Articles

High Frequency of Circulating Endothelial Colony Forming Cells (ECFCs) in Myeloproliferative Neoplasms (MPNs) Is Associated with Diagnosis of Prefibrotic Myelofibrosis, History of Splanchnic Vein Thrombosis, and Vascular Splenomegaly.

Vittorio Rosti, MD, Elisa Bonetti, Gaetano Bergamaschi, MD, Rita Campanelli, PhD, Elisabetta Gattoni, MD, Sonia Lo Po, Umberto Magrini, MD, Margherita Massa, PhD, Alessandro Vannucchi, MD, Gianluca Viarengo, MD, Paola Guglielmelli, MD, Massimo Primignani, MD, Giovanni Barosi, MD

Blood (2009) 114 (22): 309.

https://doi.org/10.1182/blood.V114.22.309.309

Published: 2009

Journal Articles

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker

Blood (2009) 114 (14): 3127–3130.

https://doi.org/10.1182/blood-2008-12-190991

Published: 2009

Journal Articles

Kinetics of CD34+ Cells in the Peripheral Blood of Patients with Primary Myelofibrosis Undergoing Splenectomy

Rita Campanelli, PhD, Margherita Massa, PhD, Elisa Bonetti, Gianluca Viarengo, MD, Vittorio Rosti, MD, Elisabetta Gattoni, MD, Enza Moretti, Gaetano Bergamaschi, MD, Laura Villani, PhD, Marco Lucioni, MD, Laura Bandiera, MD, Roberta Riboni, PhD, Gianni Barosi, MD

Blood (2008) 112 (11): 3725.

https://doi.org/10.1182/blood.V112.11.3725.3725

Published: 2008

Journal Articles

JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis

Giovanni Barosi, Gaetano Bergamaschi, Monia Marchetti, Alessandro M. Vannucchi, Paola Guglielmelli, Elisabetta Antonioli, Margherita Massa, Vittorio Rosti, Rita Campanelli, Laura Villani, Gianluca Viarengo, Elisabetta Gattoni, Giancarla Gerli, Giorgina Specchia, Carmine Tinelli, Alessandro Rambaldi, Tiziano Barbui

Blood (2007) 110 (12): 4030–4036.

https://doi.org/10.1182/blood-2007-07-099184

Published: 2007

Includes: Supplemental data

Journal Articles

Circulating Endothelial Progenitor Cells Are Increased in Patients with Myelofibrosis and Do Not Harbor V617F JAK-2 or W515L MPL Mutations

Elisa Bonetti, Vittorio Rosti, MD, Laura Villani, PhD, Rita Campanelli, PhD, Gaetano Bergamaschi, MD, Margherita Massa, PhD, Alessandro Pecci, MD, Alessandro M. Vannucchi, MD, Francesco Frassoni, MD, Giovanni Barosi, MD

Blood (2007) 110 (11): 1535.

https://doi.org/10.1182/blood.V110.11.1535.1535

Published: 2007

Journal Articles

Reduced CD26 Dipeptidylpeptidase IV Membrane Expression and Activity of CD34+ Cells from Patients with Myelofibrosis with Myeloid Metaplasia.

Rita Campanelli, Margherita Massa, PhD, Vittorio Rosti, MD, Gaetano Bergamaschi, MD, Gianluca Viarengo, MD, Monia Marchetti, MD, Ronald Hoffman, MD, Giovanni Barosi, MD

Blood (2006) 108 (11): 3617.

https://doi.org/10.1182/blood.V108.11.3617.3617

Published: 2006

Journal Articles

Incidence and Clinical Profile of JAK2 V617F Mutation in Myelofibrosis with Myeloid Metaplasia.

Giovanni Barosi, MD, Monia Marchetti, MD, Margherita Massa, PhD, Vittorio Rosti, MD, Alessandro Vannucchi, MD, Rosangela Invernizzi, MD, Rita Campanelli, BSc, Gianluca Viarengo, MD, Umberto Magrini, PhD, Gaetano Bergamaschi, MD

Blood (2005) 106 (11): 256.

https://doi.org/10.1182/blood.V106.11.256.256

Published: 2005

Journal Articles

Evidence of Polyclonal Hematopoiesis in a Large Proportion of Patients with Low-Risk Myelodysplastic Syndrome.

Luca Malcovati, MD, Matteo G. Della Porta, MD, Anna Galli, BS, Sabrina Boggi, BS, Lucia Malabarba, MD, Daniela Pietra, BS, Francesco Passamonti, MD, Gaetano Bergamaschi, MD, Mario Lazzarino, MD, Mario Cazzola, MD

Blood (2004) 104 (11): 2364.

https://doi.org/10.1182/blood.V104.11.2364.2364

Published: 2004

Journal Articles

Clonal Origin of Circulating Endothelial Progenitor Cells in Patients with Myelofibrosis with Myeloid Metaplasia.

Gaetano Bergamaschi, MD, Tiziano Pramparo, PhD, Vittorio Rosti, MD, Isabella Ramajoli, PhD, Giuliana Gregato, PhD, Margherita Massa, PhD, Monia Marchetti, MD, Orsetta Zuffardi, PhD, Mario Cazzola, MD, Giovanni Barosi, MD

Blood (2004) 104 (11): 2427.

https://doi.org/10.1182/blood.V104.11.2427.2427

Published: 2004

Journal Articles

Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia

Mario Cazzola, Rosangela Invernizzi, Gaetano Bergamaschi, Sonia Levi, Barbara Corsi, Erica Travaglino, Valeria Rolandi, Giorgio Biasiotto, Jim Drysdale, Paolo Arosio

Blood (2003) 101 (5): 1996–2000.

https://doi.org/10.1182/blood-2002-07-2006

Published: 2003

Journal Articles

Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation

Mario Cazzola, Alison May, Gaetano Bergamaschi, Paola Cerani, Sara Ferrillo, David F. Bishop

Blood (2002) 100 (12): 4236–4238.

https://doi.org/10.1182/blood-2002-03-0685

Published: 2002

Journal Articles

Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females

Mario Cazzola, Alison May, Gaetano Bergamaschi, Paola Cerani, Vittorio Rosti, David F. Bishop

Blood (2000) 96 (13): 4363–4365.

https://doi.org/10.1182/blood.V96.13.4363

Published: 2000

Journal Articles

Juvenile Genetic Hemochromatosis Is Clinically and Genetically Distinct From the Classical HLA-Related Disorder

Mario Cazzola, Paola Cerani, Andrea Rovati, Angioletta Iannone, Giovanni Claudiani, Gaetano Bergamaschi

Blood (1998) 92 (8): 2979–2981.

https://doi.org/10.1182/blood.V92.8.2979

Published: 1998

Journal Articles

Hereditary Hyperferritinemia-Cataract Syndrome: Relationship Between Phenotypes and Specific Mutations in the Iron-Responsive Element of Ferritin Light-Chain mRNA

Mario Cazzola, Gaetano Bergamaschi, Laura Tonon, Eloisa Arbustini, Maurizia Grasso, Elena Vercesi, Giovanni Barosi, Paolo Emilio Bianchi, Gaetano Cairo, Paolo Arosio

Blood (1997) 90 (2): 814–821.

https://doi.org/10.1182/blood.V90.2.814

Published: 1997

NARROW

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2 V617F mutation

JAK2 exon 14 Skipping in Patients with Primary Myelofibrosis (PMF),

The Effects of Mitochondrial Ferritin Expression in Normal and Sideroblastic Erythropoiesis.

High Frequency of Circulating Endothelial Colony Forming Cells (ECFCs) in Myeloproliferative Neoplasms (MPNs) Is Associated with Diagnosis of Prefibrotic Myelofibrosis, History of Splanchnic Vein Thrombosis, and Vascular Splenomegaly.

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker

Kinetics of CD34+ Cells in the Peripheral Blood of Patients with Primary Myelofibrosis Undergoing Splenectomy

JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis

Circulating Endothelial Progenitor Cells Are Increased in Patients with Myelofibrosis and Do Not Harbor V617F JAK-2 or W515L MPL Mutations

Reduced CD26 Dipeptidylpeptidase IV Membrane Expression and Activity of CD34+ Cells from Patients with Myelofibrosis with Myeloid Metaplasia.

Incidence and Clinical Profile of JAK2 V617F Mutation in Myelofibrosis with Myeloid Metaplasia.

Evidence of Polyclonal Hematopoiesis in a Large Proportion of Patients with Low-Risk Myelodysplastic Syndrome.

Clonal Origin of Circulating Endothelial Progenitor Cells in Patients with Myelofibrosis with Myeloid Metaplasia.

Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia

Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation

Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females

Juvenile Genetic Hemochromatosis Is Clinically and Genetically Distinct From the Classical HLA-Related Disorder

Hereditary Hyperferritinemia-Cataract Syndrome: Relationship Between Phenotypes and Specific Mutations in the Iron-Responsive Element of Ferritin Light-Chain mRNA

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only